Stocks
Alnylam Pharmaceuticals (ALNY) CAPEX/Revenue US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| CAPEX/Revenue, % | 63.8% | 14.3% | 9.05% | 6.95% | 3.40% | 1.93% | |||
| Changes by years, y/y, % | -106pp | -50pp | -5pp | -2pp | -4pp | -54.2% | |||
Alnylam Pharmaceuticals. CAPEX/Revenue, %
Alnylam Pharmaceuticals. CAPEX/Revenue, changes, pp
Alnylam Pharmaceuticals (ALNY) CAPEX/Revenue US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| CAPEX/Revenue, % | 2.28% | 3.48% | 2.62% | 1.22% | 0.84% | 1.93% | ||
| Changes by years, y/y, % | -4pp | -3pp | -2pp | -4pp | -1pp | |||
| Changes by quarters, q/q, % | -3pp | +1pp | -1pp | -1pp | 0pp | |||
